Latest filing published 24 Feb 2022 for West Pharmaceutical Services INC, €1.2M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David A. Montecalvo: trading record in brief
David A. Montecalvo (senior executive) discloses dealings in West Pharmaceutical Services Inc to SEC (Form 4). We count 21 filings; the first trade dates from 26 September 2016 and the latest from 22 February 2022.
Every open-market trade on record is a sale: 6 sales worth €4.0M. Besides market trades, the filings include 12 share grants and 3 option exercises.
Most recently, on 24 February 2022, the filings show a share grant worth €1.2M in West Pharmaceutical Services Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David A. Montecalvo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,597 shares@ US$369.1382.4% of flowCommon StockSEC:0001562180-22-001906:0
- 27 shares@ US$391.200.6% of flowCommon StockSEC:0001562180-22-001454:0
- 620 shares@ US$457.1117.0% of flowCommon StockSEC:0001562180-21-006112:0
3 of 3 declarations
